4.5 Article

Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia

Journal

JOURNAL OF HEADACHE AND PAIN
Volume 15, Issue -, Pages -

Publisher

SPRINGEROPEN
DOI: 10.1186/1129-2377-15-78

Keywords

Trigeminal neuralgia; Pain processing; Transcranial direct current stimulation; Clinical electrophysiology

Funding

  1. Astellas
  2. CSL Behring
  3. Grunental
  4. Allergan
  5. Biogen Idec
  6. Novartis
  7. Sanofi-Aventis
  8. Genzyme
  9. Pfizer
  10. Teva
  11. Electrocore
  12. German Ministry for Education and Research (BMBF)
  13. Almirall
  14. AstraZeneca
  15. Bayer
  16. Galaxo-Smith-Kline
  17. Janssen-Cilag
  18. German Research Council (DFG)
  19. German Ministry of Education and Research (BMBF)
  20. European Union

Ask authors/readers for more resources

Background: Transcranial direct current stimulation (tDCS) of the primary motor cortex has been shown to modulate pain and trigeminal nociceptive processing. Methods: Ten patients with classical trigeminal neuralgia (TN) were stimulated daily for 20 minutes over two weeks using anodal (1 mA) or sham tDCS over the primary motor cortex (M1) in a randomized double-blind cross-over design. Primary outcome variable was pain intensity on a verbal rating scale (VRS 0-10). VRS and attack frequency were assessed for one month before, during and after tDCS. The impact on trigeminal pain processing was assessed with pain-related evoked potentials (PREP) and the nociceptive blink reflex (nBR) following electrical stimulation on both sides of the forehead before and after tDCS. Results: Anodal tDCS reduced pain intensity significantly after two weeks of treatment. The attack frequency reduction was not significant. PREP showed an increased N2 latency and decreased peak-to-peak amplitude after anodal tDCS. No severe adverse events were reported. Conclusion: Anodal tDCS over two weeks ameliorates intensity of pain in TN. It may become a valuable treatment option for patients unresponsive to conventional treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available